Contribute Try STAT+ Today

Hello, everyone, and how are you today? We are doing just fine, thank you, despite gloomy skies hovering over the Pharmalot campus. Two short people are hunched over laptops, and the official mascot is busy gnawing on chew toys (instead of furniture). All of this means that we are left to tend to matters at hand, such as brewing cups of stimulation, tuning in to Zoom calls and foraging for interesting items. Speaking of which, here are some tidbits to help you on your own journey. Hope all goes well today, and, of course, stay safe — wear a mask. …

Pfizer (PFE) is not yet ready to release data from the late-stage trial of the Covid-19 vaccine candidate it is developing with BioNTech (BNTX), Reuters writes. Pfizer chief executive officer Albert Bourla has said the company could release data on whether or not the vaccine works as early as this month, but the company said in a presentation on Tuesday that the independent data monitoring board that will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy